LYEL
Price
$1.19
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
32 days until earnings call
TSHA
Price
$2.02
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
40 days until earnings call
Ad is loading...

LYEL vs TSHA

Header iconLYEL vs TSHA Comparison
Open Charts LYEL vs TSHABanner chart's image
Lyell Immunopharma
Price$1.19
Change-$0.00 (-0.00%)
Volume$346.72K
CapitalizationN/A
Taysha Gene Therapies
Price$2.02
Change-$0.00 (-0.00%)
Volume$2.33M
CapitalizationN/A
View a ticker or compare two or three
LYEL vs TSHA Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
LYEL vs. TSHA commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Buy and TSHA is a Sell.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (LYEL: $1.19 vs. TSHA: $2.02)
Brand notoriety: LYEL and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 50% vs. TSHA: 155%
Market capitalization -- LYEL: $353.28M vs. TSHA: $424.23M
LYEL [@Biotechnology] is valued at $353.28M. TSHA’s [@Biotechnology] market capitalization is $424.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 2 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 6 bearish.
  • TSHA’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than TSHA.

Price Growth

LYEL (@Biotechnology) experienced а -21.71% price change this week, while TSHA (@Biotechnology) price change was -3.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

LYEL is expected to report earnings on Nov 05, 2024.

TSHA is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($424M) has a higher market cap than LYEL($353M). TSHA YTD gains are higher at: 14.124 vs. LYEL (-38.660). TSHA has higher annual earnings (EBITDA): -110.75M vs. LYEL (-205.56M). LYEL has more cash in the bank: 491M vs. TSHA (173M). LYEL has less debt than TSHA: LYEL (53.3M) vs TSHA (57.7M). TSHA has higher revenues than LYEL: TSHA (12.9M) vs LYEL (54K).
LYELTSHALYEL / TSHA
Capitalization353M424M83%
EBITDA-205.56M-110.75M186%
Gain YTD-38.66014.124-274%
P/E RatioN/A8.49-
Revenue54K12.9M0%
Total Cash491M173M284%
Total Debt53.3M57.7M92%
TECHNICAL ANALYSIS
Technical Analysis
LYELTSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DREQX20.01-0.02
-0.10%
BNY Mellon Research Growth Z
TGFRX47.37-0.12
-0.25%
Tanaka Growth
CSECX39.53-0.21
-0.53%
Calvert Equity C
HIGCX22.13-0.12
-0.54%
Carillon Eagle Growth & Income C
ADNPX12.19-0.13
-1.06%
American Beacon ARK Transfmt Innov Inv

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with QSI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-3.25%
QSI - LYEL
49%
Loosely correlated
+0.52%
NTLA - LYEL
49%
Loosely correlated
-4.85%
ADPT - LYEL
48%
Loosely correlated
-1.56%
PGEN - LYEL
46%
Loosely correlated
-4.75%
VCYT - LYEL
46%
Loosely correlated
-2.44%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-1.46%
LOGC - TSHA
45%
Loosely correlated
+2.29%
LYEL - TSHA
40%
Loosely correlated
-3.25%
PGEN - TSHA
40%
Loosely correlated
-4.75%
TERN - TSHA
39%
Loosely correlated
N/A
ABOS - TSHA
39%
Loosely correlated
-4.40%
More